{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:04:53Z","timestamp":1784275493032,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06194-1","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:34:33Z","timestamp":1781328873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical, serological, and hematological profiles according to age at diagnosis in primary Sj\u00f6gren disease: a single-center cross-sectional study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8397-6815","authenticated-orcid":false,"given":"Gulnur Celik","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7219-1457","authenticated-orcid":false,"given":"Hakan","family":"Apaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-0490","authenticated-orcid":false,"given":"Ruveyda Sak","family":"Inal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8843-7033","authenticated-orcid":false,"given":"Ayse Tugcenur Temiz","family":"Gencoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-476X","authenticated-orcid":false,"given":"Emine Gozde Aydemir","family":"Guloksuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-2124","authenticated-orcid":false,"given":"Murat","family":"Erdugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3886-4093","authenticated-orcid":false,"given":"Ekin Basak","family":"Doganci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"6194_CR1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41584-025-01268-z","volume":"21","author":"M Ramos-Casals","year":"2025","unstructured":"Ramos-Casals M, Baer AN, Brito-Zer\u00f3n MdP et al (2025) 2023 International Rome consensus for the nomenclature of Sj\u00f6gren disease. Nat Rev Rheumatol 21:426\u2013437. https:\/\/doi.org\/10.1038\/s41584-025-01268-z","journal-title":"Nat Rev Rheumatol"},{"key":"6194_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3821","volume":"344","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Sis\u00f3-Almirall A, Bosch X (2012) Primary Sjogren syndrome. BMJ 344:e3821. https:\/\/doi.org\/10.1136\/bmj.e3821","journal-title":"BMJ"},{"key":"6194_CR3","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette X, Criswell LA (2018) Primary Sj\u00f6gren\u2019s syndrome. N Engl J Med 378:931\u2013939. https:\/\/doi.org\/10.1056\/NEJMcp1702514","journal-title":"N Engl J Med"},{"key":"6194_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594096","volume":"11","author":"AV Goules","year":"2020","unstructured":"Goules AV, Argyropoulou OD, Pezoulas VC et al (2020) Primary Sj\u00f6gren\u2019s syndrome of early and late onset: distinct clinical phenotypes and lymphoma development. Front Immunol 11:594096. https:\/\/doi.org\/10.3389\/fimmu.2020.594096","journal-title":"Front Immunol"},{"key":"6194_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/rheumatology\/key392","volume":"58","author":"C Anquetil","year":"2019","unstructured":"Anquetil C, Hachulla E, Machuron F et al (2019) Is early-onset primary Sj\u00f6gren\u2019s syndrome a worse prognosis form of the disease? Rheumatology (Oxford) 58:1163\u20131167. https:\/\/doi.org\/10.1093\/rheumatology\/key392","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 133","key":"6194_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.55563\/clinexprheumatol\/egnd1i","volume":"39","author":"S Retamozo","year":"2021","unstructured":"Retamozo S, Acar-Denizli N, Horv\u00e1th IF et al (2021) Influence of the age at diagnosis in the disease expression of primary Sj\u00f6gren syndrome. Analysis of 12,753 patients from the Sj\u00f6gren Big Data Consortium. Clin Exp Rheumatol 39(Suppl 133):166\u2013174. https:\/\/doi.org\/10.55563\/clinexprheumatol\/egnd1i","journal-title":"Clin Exp Rheumatol"},{"key":"6194_CR7","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/annrheumdis-2016-209952","volume":"76","author":"P Brito-Zer\u00f3n","year":"2017","unstructured":"Brito-Zer\u00f3n P, Acar-Denizli N, Zeher M et al (2017) Influence of geolocation and ethnicity on the phenotypic expression of primary Sj\u00f6gren\u2019s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sj\u00f6gren Project Consortium. Ann Rheum Dis 76:1042\u20131050. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209952","journal-title":"Ann Rheum Dis"},{"key":"6194_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1183\/16000617.0011-2016","volume":"25","author":"T Flament","year":"2016","unstructured":"Flament T, Bigot A, Chaigne B et al (2016) Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome. Eur Respir Rev 25:110\u2013123. https:\/\/doi.org\/10.1183\/16000617.0011-2016","journal-title":"Eur Respir Rev"},{"key":"6194_CR9","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.3390\/jcm12072586","volume":"12","author":"O Berardicurti","year":"2023","unstructured":"Berardicurti O, Marino A, Genovali I et al (2023) Interstitial lung disease and pulmonary damage in primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. J Clin Med 12:2586. https:\/\/doi.org\/10.3390\/jcm12072586","journal-title":"J Clin Med"},{"key":"6194_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.chest.2020.10.011","volume":"159","author":"AS Lee","year":"2021","unstructured":"Lee AS, Scofield RH, Hammitt KM et al (2021) Consensus guidelines for evaluation and management of pulmonary disease in Sj\u00f6gren\u2019s. Chest 159:683\u2013698. https:\/\/doi.org\/10.1016\/j.chest.2020.10.011","journal-title":"Chest"},{"key":"6194_CR11","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s10067-023-06596-7","volume":"42","author":"Y Huang","year":"2023","unstructured":"Huang Y, Qiu Y, Xie Z et al (2023) Risk factors and prognosis of interstitial lung disease for primary Sj\u00f6gren syndrome patients: a retrospective case\u2013control study. Clin Rheumatol 42:3033\u20133041. https:\/\/doi.org\/10.1007\/s10067-023-06596-7","journal-title":"Clin Rheumatol"},{"key":"6194_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152886","volume":"76","author":"A Manfredi","year":"2026","unstructured":"Manfredi A, Vacchi C, Cerri S et al (2026) Prevalence, incidence and mortality of interstitial lung disease in patients with Sjogren disease: data from the prospective observational EMERGE study. Semin Arthritis Rheum 76:152886. https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152886","journal-title":"Semin Arthritis Rheum"},{"key":"6194_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.advms.2024.12.001","volume":"70","author":"G Sargin","year":"2025","unstructured":"Sargin G, Baris K, Gulen ST (2025) Systemic immune-inflammation index in the evaluation of Sjogren\u2019s syndrome associated with interstitial lung disease, interstitial pneumonia with autoimmune features, and idiopathic pulmonary fibrosis. Adv Med Sci 70:57\u201361. https:\/\/doi.org\/10.1016\/j.advms.2024.12.001","journal-title":"Adv Med Sci"},{"issue":"10","key":"6194_CR14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A (2018) Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 14(10):576\u2013590. https:\/\/doi.org\/10.1038\/s41574-018-0059-4. (PMID: 30046148)","journal-title":"Nat Rev Endocrinol."},{"key":"6194_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.clinbiochem.2014.08.022","volume":"47","author":"ZD Hu","year":"2014","unstructured":"Hu ZD, Sun Y, Guo J et al (2014) Red blood cell distribution width and neutrophil\/lymphocyte ratio are positively correlated with disease activity in primary Sj\u00f6gren\u2019s syndrome. Clin Biochem 47:287\u2013290. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.08.022","journal-title":"Clin Biochem"},{"key":"6194_CR16","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.55563\/clinexprheumatol\/f0jnnm","volume":"42","author":"J Mercader-Salvans","year":"2024","unstructured":"Mercader-Salvans J, Garc\u00eda-Gonz\u00e1lez M, Quevedo-Abeledo JC et al (2024) Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosus. Clin ExpRheumatol 42:1773\u20131780. https:\/\/doi.org\/10.55563\/clinexprheumatol\/f0jnnm","journal-title":"Clin ExpRheumatol"},{"key":"6194_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/OARRR.S424168","volume":"15","author":"M Alghamdi","year":"2023","unstructured":"Alghamdi M (2023) Red blood cell distribution width: a potential inexpensive marker for disease activity in patients with rheumatic diseases; scoping review. Open Access Rheumatol 15:173\u2013180. https:\/\/doi.org\/10.2147\/OARRR.S424168","journal-title":"Open Access Rheumatol"},{"key":"6194_CR18","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00296-024-05626-0","volume":"44","author":"RA Saleem","year":"2024","unstructured":"Saleem RA, Ramadan M, Elshaaer Y et al (2024) Laboratory features and pharmacological management of early and late-onset primary Sj\u00f6gren\u2019s syndrome. Rheumatol Int 44:1317\u20131325. https:\/\/doi.org\/10.1007\/s00296-024-05626-0","journal-title":"Rheumatol Int"},{"key":"6194_CR19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00296-009-1152-8","volume":"30","author":"V Yazisiz","year":"2010","unstructured":"Yazisiz V, Arslan G, Ozbudak IH et al (2010) Lung involvement in patients with primary Sj\u00f6gren\u2019s syndrome: What are the predictors? Rheumatol Int 30:1317\u20131324. https:\/\/doi.org\/10.1007\/s00296-009-1152-8","journal-title":"Rheumatol Int"},{"key":"6194_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00296-017-3678-5","volume":"37","author":"V Strevens Bolmgren","year":"2017","unstructured":"Strevens Bolmgren V, Olsson P, Wollmer P et al (2017) Respiratory symptoms are poor predictors of concomitant chronic obstructive pulmonary disease in patients with primary Sj\u00f6gren\u2019s syndrome. Rheumatol Int 37:813\u2013818. https:\/\/doi.org\/10.1007\/s00296-017-3678-5","journal-title":"Rheumatol Int"},{"key":"6194_CR21","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"6194_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R et al (2017) 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76:9\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210571","journal-title":"Ann Rheum Dis"},{"key":"6194_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ et al (2010) EULAR Sj\u00f6gren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 69:1103\u20131109. https:\/\/doi.org\/10.1136\/ard.2009.110619","journal-title":"Ann Rheum Dis"},{"key":"6194_CR24","unstructured":"World Medical Association (2024) WMA Declaration of Helsinki: ethical principles for medical research involving human participants. Adopted by the 75th WMA General Assembly, Helsinki, Finland, October 2024. Accessed 10 April 2026"},{"key":"6194_CR25","doi-asserted-by":"publisher","unstructured":"Konak HE, Atalar E, Hezer H et al (2024) Interstitial lung disease in primary Sj\u00f6gren\u2019s syndrome: risk factors for occurrence and radiographic progression. Sarcoidosis Vasc Diffuse Lung Dis 41:e2024035. https:\/\/doi.org\/10.36141\/svdld.v41i3.15548","DOI":"10.36141\/svdld.v41i3.15548"},{"key":"6194_CR26","doi-asserted-by":"publisher","first-page":"12461","DOI":"10.3389\/abp.2024.12461","volume":"71","author":"Z Yang","year":"2024","unstructured":"Yang Z, Zhao H, Shan L, Wang D (2024) Clinical features and risk factors for primary Sj\u00f6gren\u2019s syndrome combined with interstitial lung disease: a retrospective study. Acta Biochim Pol 71:12461. https:\/\/doi.org\/10.3389\/abp.2024.12461","journal-title":"Acta Biochim Pol"},{"key":"6194_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X241305218","author":"M Madej","year":"2024","unstructured":"Madej M, Proc K, Wawryka P et al (2024) The analysis of the pulmonary domain involvement in Sj\u00f6gren\u2019s disease. Ther Adv Musculoskelet Dis. https:\/\/doi.org\/10.1177\/1759720X241305218","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"6194_CR28","doi-asserted-by":"publisher","first-page":"17364","DOI":"10.36141\/svdld.v42i3.17364","volume":"42","author":"Z Ozsoy","year":"2025","unstructured":"Ozsoy Z, Ozdemirel T\u015e, Ensar\u0131o\u011flu K et al (2025) Evaluation of patients diagnosed with primary Sjogren\u2019s syndrome with and without pulmonary involvement. Sarcoidosis Vasc Diffuse Lung Dis 42:17364. https:\/\/doi.org\/10.36141\/svdld.v42i3.17364","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"6194_CR29","doi-asserted-by":"publisher","first-page":"1806321","DOI":"10.3389\/fimmu.2026.1806321","volume":"17","author":"R Liu","year":"2026","unstructured":"Liu R, Zhi L, Liang Y et al (2026) Clinical features, diagnosis, and treatment of primary Sj\u00f6gren\u2019s disease with interstitial lung disease: a narrative review. Front Immunol 17:1806321. https:\/\/doi.org\/10.3389\/fimmu.2026.1806321","journal-title":"Front Immunol"},{"key":"6194_CR30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.5152\/ArchRheumatol.2025.25012","volume":"40","author":"A \u00d6zdo\u011fan Bircan","year":"2025","unstructured":"\u00d6zdo\u011fan Bircan A, Zengin Acemo\u011flu \u015e\u015e, T\u00fcrk \u0130, Elbek \u00d6zer HT (2025) Immunonutritional biomarkers in primary Sj\u00f6gren\u2019s syndrome disease activity: CALLY index and HALP score. Arch Rheumatol 40:376\u2013384. https:\/\/doi.org\/10.5152\/ArchRheumatol.2025.25012","journal-title":"Arch Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06194-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06194-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06194-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:17:01Z","timestamp":1784272621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06194-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["6194"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06194-1","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"4 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Owing to the retrospective design of the study and the use of anonymized patient data, the requirement for written informed consent was waived by the ethics committee.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No part of this report has been copied from or published elsewhere, in whole or in part.","order":3,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ankara Etlik City Hospital Clinical Research Ethics Committee with the approval protocol number AESH-BADEK2-2026-325 on [approval date 21.04.2026]. The study was conducted in accordance with the ethical principles of the World Medical Association Declaration of Helsinki, October 2024 version.","order":4,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external commercial editing or paid professional language- editing service was used for this manuscript.","order":5,"name":"Ethics","label":"External commercial editing support","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work has not been previously presented or published as a congress abstract.","order":6,"name":"Ethics","label":"Note on prior presentation","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that this manuscript is original and that no part of this report has been copied, published, or submitted elsewhere, either in whole or in part.","order":7,"name":"Ethics","label":"Originality and prior publication statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ChatGPT, GPT-5.5 Thinking model by OpenAI, was used on April 2026 solely for language editing. All AI-assisted edits were reviewed and approved by the authors, who take full responsibility for the accuracy, integrity, and final content of the manuscript.","order":8,"name":"Ethics","label":"Use of artificial intelligence and editing support","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"148"}}